Qcdx
Manufacturing · Connecticut, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
400 Farmington Ave # R1809, Farmington, ...Phone Number
(860) 679-4673Website
www.qcd-x.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Qcdx
QCDx is a medical device company focused on early detection of circulating tumor cells (CTCs) to provide precision cancer diagnoses. Their innovative technology allows for enrichment-free profiling and isolation of rare CTCs, facilitating real-time cancer intelligence through minimally invasive blood tests. QCDx's solutions aim to optimize treatment, monitor therapy, and assess treatment toxicity, thereby improving patient outcomes and quality of life. Their products cater to oncologists and pharmaceutical industries, supporting cancer research and drug discovery across all stages.Explore more
Qcdx Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Qcdx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Qcdx
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Qcdx recently announced quarterly report
Click to see if Qcdx had a recent Job posting/layoffs
Check if Qcdx has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Qcdx launches new products
Funding: Get notified immidiatlly once Qcdx has new funding data
Check out if Qcdx is spiking on competitors!
Qcdx, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Qcdx
Compare insights from companies similar to Qcdx, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Qcdx is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Qcdx is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Qcdx.
Qcdx financials insights
Gather financial insights about Qcdx, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$14K
2025
Other Financing Round
$7M
Qcdx Tech Stack
A closer look at the technologies used by Qcdx
See more technologies
Most Recent Scoops
New Hire
Executive Move
Lisette Grunwell has recently joined the organization as Chief Quality & Regulatory Officer.
Executive Moves, New Hire
Funding
Funding
Funding
Qcdx has received an SBA PPP loan in the amount of $14,381 from Webster Bank resulting in the retention of 1 jobs.
Funding
Qcdx News & Media
QCDx Announces Clinical Study for the Determination of Clinical...
QCDx’s technology provides in-depth information for early cancer diagnosis, optimization and monitoring efficacy of treatment and early detection of disease recurrence (PRWeb June 03, 2020) Read the full story at https://www.prweb.com/releases/qcdx_announces_clinical_study_for_the_determination_of_clinical_utility_of_the_qcdx_br_liquid_biopsy_system_to_optimize_treatment_options_for_breast_cancer/prweb17165406.htmQCDx Announces Sale of the RareScope to the Carole and Ray Neag Comprehensive Cancer Center at UConn Health for Use in Clinical Research
QCDx’s technology provides in-depth information for early cancer detection and treatment optimization for clinical trials of novel therapies and for companion diagnostic development (PRWeb January 21, 2020) Read the full story at https://www.prweb.com/releases/qcdx_announces_sale_of_the_rarescope_to_the_carole_and_ray_neag_comprehensive_cancer_center_at_uconn_health_for_use_in_clinical_research/prweb16845956.htm
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Qcdx
Sign Up For FreeTo access detailed company insights
QCDx is a medical device company focused on early detection of circulating tumor cells (CTCs) to provide precision cancer diagnoses. Their innovative technology allows for enrichment-free profiling and isolation of rare CTCs, facilitating real-time cancer intelligence through minimally invasive blood tests. QCDx's solutions aim to optimize treatmen... Read More
